Welcome Address for the 19th Annual Congress of the German Transplantation Society (Deutsche Transplantationsgesellschaft, DTG) in Hamburg 2010
REDUCED DOSE-ADAPTED MMF EXPOSURE UNDER PROTON PUMP INHIBITOR CO-MEDICATION IN STABLE HEART TRANSPLANT RECIPIENTS
DONATION AFTER CARDIAC DEATH: DYNAMIC GRAFT RECONDITIONING DURING OR AFTER ISCHEMIC PRESERVATION?
ROLE OF THE CYP2D6 POOR METABOLIZER STATUS ON THE FIBROSIS PROGRESSION AFTER LIVER TRANSPLANTATION
IMPACT OF IMMUNOSUPPRESSIVE THERAPY ON HEPATITIS C INFECTION AFTER RENAL TRANSPLANTATION
ABERRANT ACTIVATION OF COAGULATION IS INDEPENDENT OF XENOREACTIVE ANTIBODY TITER AND COMPLEMENT ACTIVATION IN EX VIVO PERFUSION OF PORCINE KIDNEYS
UW SOLUTION PRESERVES ORGAN QUALITY IN RENAL GRAFTS SIGNIFICANTLY BETTER THAN HTK SOLUTION AFTER PROLONGED COLD ISCHEMIA TIME: A COMPARATIVE EXPERIMENTAL STUDY
N-OCTANOYL-DOPAMINE IS MORE POTENT THAN DOPAMINE IN REDUCING INFLAMMATION AND IMPROVING RENAL FUNCTION IN ACUTE RENAL FAILURE
RAPIDLY PROGRESSIVE HEPATIC ALVEOLAR ECHINOCOCCOSIS IN AN ABO-INCOMPATIBLE RENAL TRANSPLANT RECIPIENT
LISTING FOR TRANSPLANTATION IN PATIENTS WITH DILATED CARDIOMYOPATHY AND EVIDENCE OF BETA-1 ADRENOCEPTOR AUTOANTIBODIES CAN BE DELAYED BY IMMUNOADSORBTION THERAPY
ECHOCARDIOGRAPHY CAN PREDICT SHORT-TERM COURSE OF RIGHT HEART FAILURE IN PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION REFERRED FOR TRANSPLANTATION
IMPACT OF MAINTENANCE IMMUNOSUPPRESSIVE REGIMENS -BALANCE BETWEEN GRAFT PROTECTIVE SUPPRESSION OF IMMUNE FUNCTIONS AND A NEAR PHYSIOLOGICAL IMMUNE RESPONSE
RISK FACTORS OF KIDNEY GRAFT SURVIVAL: THE IMPACT OF INTRA-OPERATIVE HIGH-DOSE INDUCTION WITH ATG-FRESENIUS AND IDENTIFICATION OF RELIABLE PROGNOSTIC FACTORS
ONCE-DAILY TAC EXTENDED-RELEASE FORMULATION: 1 YEAR-POST-CONVERSION IN STABLE PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
CUTANEOUS TUBERCULOSIS MIMICKING ERISYPELAS OF THE LOWER LEG IN A HEART TRANSPLANT RECIPIENT
REACHING THE ORIGINAL GFR OF A SINGLE KIDNEY AFTER LIVING DONOR TRANSPLANTATION: IMPACT OF DONOR AND RECIPIENT CHARACTERISTICS
INSUFFICIENCY OF THE CLASSICAL CDC-BASED CROSS MATCH TO DETECT DONOR-SPECIFIC ANTI-HLA ANTIBODIES UNDER CERTAIN CIRCUMSTANCES AS SHOWN BY CASE REPORTS REPRESENTING THREE GROUPS OF PATIENTS
ADDITIONAL SOLID PHASE-BASED CROSS MATCH ASSAY FOR POST-MORTEM HEART AND LIVING KIDNEY TRANSPLANTATIONS TO PREDICT THE NEGATIVE INFLUENCE OF DONOR-SPECIFIC ANTI-HLA ANTIBODIES
LOBSTER - LIVER OBSERVATIONAL STUDY TO ASSESS THE EFFECT OF CELLCEPT THERAPY ON CLINICAL OUTCOMES IN LIVER TRANSPLANT PATIENTS: INTERIM RESULTS AFTER 6 MONTHS
CLINICAL OUTCOME OF HEPATITIS B VIRUS INFECTION IN PATIENTS RECEIVING HEMATOPOIETIC STEM CELL GRAFTS FROM IMMUNIZED DONORS*
HEPATITIS B VIRUS SPECIFIC IMMUNE TRANSFER IN AB0 INCOMPATIBLE LIVING DONOR LIVER TRANSPLANTATION*
PSYCHOSOCIAL IMPACT OF LIVE KIDNEY DONATION IN A SINGLE GERMAN TRANSPLANT CENTER
EXCELLENT RENAL FUNCTION, PATIENT AND GRAFT SURVIVAL WITH LONG-TERM USE OF ONCE-DAILY PROLONGED-RELEASE TACROLIMUS IN KIDNEY TRANSPLANT RECIPIENTS
RENAL FUNCTION AND SAFETY IN STABLE KIDNEY RECIPIENTS CONVERTED FROM TACROLIMUS TWICE DAILY TO A ONCE-DAILY FORMULATION
SIGNIFICANTLY BETTER FREEDOM FROM ACUTE REJECTION WITH TACROLIMUS VERSUS CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN RENAL TRANSPLANT RECIPIENTS AT 7-YEAR FOLLOW-UP
COMBINED KIDNEY 5TH -HEART-TRANSPLANTATION: GOOD LONG-TERM RESULTS AFTER SEVERE ACUTE REJECTION AND INVASIVE ZYGOMYCOTA-PNEUMONIA: A CASE REPORT
IMPACT OF EVEROLIMUS ON PERICARDIAL AND PLEURAL EFFUSIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS
MULTI-DRUG-DONOR PRECONDITIONING PROTECTS MARGINAL LIVER ORGANS AGAINST ISCHEMIA/REPERFUSION INJURY
AUTOLOGOUS TISSUE ENGINEERED HEART VALVE REPLACEMENT — THE CD133+ STEM CELL-PLUS-FIBRIN COMPOSITE BASED SPRAYED CELL SEEDING CONCEPT
LOCAL AND SYSTEMIC INFLAMMATORY RESPONSE AFTER IN-SITU SPLIT-LIVER PROCEDURE; CAN PRECONDITIONING STRATEGIES IMPROVE GRAFT QUALITY?
IMPACT OF 6 DIFFERENT IMMUNOSUPPRESSIVE REGIMENS ON RATES OF CARDIAC ALLOGRAFT REJECTION
INFLUENCE OF 6 DIFFERENT IMMUNOSUPPRESSIVE REGIMENS ON NEW ONSET DIABETES MELLITUS IN CARDIAC TRANSPLANT RECIPIENTS
THE FRAMINGHAM RISK SCORE: ESTIMATION OF CARDIOVASCULAR RISK IN 1007 HEART TRANSPLANTS RECIPIENTS
FEASIBILITY OF ALISKIREN FOR TREATMENT OF REFRACTORY ARTERIAL HYPERTENSION IN HEART TRANSPLANT RECIPIENTS
KIDNEY DYSFUNCTION AS A RISK OF SEVERE IR INJURY AFTER LIVER TRANSPLANTATION
SWITCH TO EVEROLIMUS FOR TACROLIMUS-INDUCED PANCOLITIS IN A HEART TRANSPLANT RECIPIENT: A CASE REPORT
COMBINATION OF CLOPIDOGREL AND EVEROLIMUS DRAMATICALLY REDUCED THE DEVELOPMENT OF TRANSPLANT ARTERIOSCLEROSIS
REDUCED TRANSPLANT ARTERIOSCLEROSIS AFTER TREATMENT WITH MMF AND MMF IN COMBINATION WITH GANCICLOVIR IN A MOUSE AORTIC TRANSPLANT MODEL
ROLE OF TEMPERATURE DURING GRAFT RECONDITIONING BY GASEOUS OXYGEN
EXPRESSION OF PERIPHERAL NODE ADDRESSIN (PNAD) ON ENDOTHELIAL CELLS IN SKIN OF HUMAN HAND ALLOGRAFTS
A SINGLE-CENTER-EXPERIENCE OF LIVER TRANSPLANTATION IN PATIENTS WITH ALCOHOL-TOXIC LIVER CIRRHOSIS: OUTCOME, ALCOHOL RECIDIVISM AND QUALITY OF LIFE
DE NOVO CALCINEURININHIBITOR-FREE IMMUNOSUPPRESSION WITH SIROLIMUS AND MYCOPHENOLATE MOFETIL (MMF) AFTER HEART TRANSPLANTATION: 5-YEAR RESULTS
CMV VALGANCICLOVIR PROPHYLAXIS VERSUS PREEMPTIVE THERAPY AFTER RENAL TRANSPLANTATION: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
GENE TRANSFER MAXIMIZES MESENCHYMAL STEM CELL-BASED MYOCARDIAL SALVAGE AFTER ACUTE MYOCARDIAL INFARCTION
LOCAL IMMUNOSUPPRESSION BY INHIBITION OF NFKB ACTIVATION USING INHALED TACROLIMUS
IMMUNOSUPPRESSIVE AGENTS DIFFERENTLY SUPPRESS T CELL SUBPOPULATIONS
IDENTIFYING THE POTASSIUM CHANNEL KCA3.1 AS A NEW THERAPEUTIC TARGET TO PREVENT CHRONIC AIRWAY ALLOGRAFT REJECTION
NON-VOLUME-LOADED HEART PROVIDES A MORE RELEVANT HETEROTOPIC TRANSPLANTATION MODEL
EVEROLIMUS PLUS DOSAGE REDUCTION OF CYCLOSPORIN A IN CARDIAC TRANSPLANT RECIPIENTS WITH CHRONIC KIDNEY DISEASE: A TWO-YEAR FOLLOW-UP STUDY
BENEFIT OF IMMUNSUPPRESSIVE THERAPY IN HEART TRANSPLANT RECEIPIENTS RECEIVING TACROLIMUS AND EVEROLIMUS COMPARED TO THE COMBINATION OF CICLOSPORIN A AND EVEROLIMUS
GENDER AND WORRIES ABOUT THE FAMILY AS PREDICTORS OF OUTCOMES IN THE WAITING FOR A NEW HEART STUDY
PATIENTS WITH 18-F-FDG NON-AVID HILAR CHOLANGIOCARCINOMA ON PET MAY ACHIEVE RECURRENCE-FREE LONG-TERM SURVIVAL AFTER LIVER TRANSPLANTATION
THE INFLUENCE OF HIGH-DOSE AND LOW-DOSE THERAPY WITH EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS WITH CHRONIC RENAL FAILURE
DARK SIDE OF THE MOON: SUICIDE AFTER LVAD-IMPLANTATION AS A DESTINATION THERAPY
IMPACT OF 6 DIFFERENT IMMUNOSUPPRESSIVE REGIMEN ON EFFICACY AND RENAL FUNCTION AFTER CARDIAC TRANSPLANTATION
CASE TITLE: TOXOPLASMOSIS ENCEPHALITIS THREE MONTHS AFTER HEART TRANSPLANTATION
BIOPSY-INDUCED MITRAL REGURGITATION 13 YEARS AFTER ORTOTHOPIC HEART TRANSPLANTATION
ESTIMATION OF MPA-AUC IN PATIENTS WITH TACROLIMUS TWICE DAILY AND AFTER CONVERSION TO ONCE DAILY ADMINISTRATION IN STABLE PATIENTS AFTER KIDNEY TRANSPLANTATION
PHARMACODYNAMIC MONITORING OF MTOR-INHIBITOR BASED IMMUNOSUPPRESSION IN A CELL CULTURE MODEL: ESTABLISHMENT OF A NOVEL ELISA TECHNIQUE FOR QUANTITATIVE ASSESSMENT OF PHOSPHO-P70 S6K
SUSTAINED INHIBITION OF EPSILON PROTEIN KINASE C INHIBITS VASCULAR RESTENOSIS AFTER BALLOON INJURY AND STENTING
CONVERSION FROM A CALCINEURIN INHIBITOR TO EVEROLIMUS AFTER SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION (SPK)
WILLINGNESS TO DONATE ORGANS AMONG MEDICAL STUDENTS PRIOR TO AND AFTER A LECTURE ABOUT ORGAN DONATION
IMPLANTATION OF BIOENGINEERED AV CONDUITS FOR TREATMENT OF COMPLETE AV BLOCK IN A LARGE ANIMAL MODEL
INFLUENCE OF MYCOFENOLATMOFETIL ON QUALITY OF LIFE DUE TO GASTROINTESTINAL SIDE EFFECTS FOLLOWING LIVER TRANSPLANTATION
INTESTINAL REGENERATION AND RESIDUAL FUNCTION FOLLOWING RESCUE THERAPY FOR ACUTE CELLULAR REJECTION (ACR) AFTER RAT SMALL BOWEL TRANSPLANTATION
SEVERE STENOSIS AND RIGHT VENTRICLE FISTULA OF THE LAD FOLLOWING RE-THORACOTOMY FOR HAEMOTHORAX AFTER HEART TRANSPLANTATION
ANEMIA AND EPOETIN THERAPY IN RECIPIENTS OF RENAL TRANSPLANTS: A SINGLE CENTER SURVEY
IS ECMO SUPPORT USEFUL FOR GRAFT FAILURE AFTER HEART TRANSPLANTATION?
ADENOVIRAL TRANSFER IN THE LIVER: A NOVEL IN VIVO SIMULATION MODEL IN THE RAT
EFFICACY AND SAFETY OF SUBCUTANEOUS HUMAN HBV -IMMUNOGLOBULIN (ZUTECTRA®) IN LIVER TRANSPLANTATION: AN OPEN, PROSPECTIVE, SINGLE-ARM PHASE III STUDY
RENAL FUNCTION AND SAFETY POST-CONVERSION FROM TWICE-DAILY TO ONCE-DAILY TACROLIMUS: A MULTICENTER, CROSSOVER TRIAL IN LIVER TRANSPLANT RECIPIENTS
LIPIDOMIC PROFILING OF ISOLATED PANCREATIC ISLETS PREDICTS SURVIVAL IN VITRO AND IN VIVO
ASSESSMENT OF ENDOTHELIAL FUNCTION AND HEART FAILURE PARAMETERS IN HEART TRANSPLANT AND NON-TRANSPLANT PATIENTS
EARLY POSTTRANSPLANT HEPATIC VENOUS OUTFLOW OBSTRUCTION IN CHILDREN FOLLOWING SPLIT-OR LIVING RELATED LIVER GRAFTS: SUCCESSFUL APPLICATION OF PERCUTANEOUS BALLOON DILATATION
MHC-BOUND PEPTIDES AS DETERMINANTS OF NATURAL HLA ANTIBODY SPECIFICITY
POLYMORPHISMS OF MANNOSE-BINDING LECTIN-2-GENE ARE ASSOCIATED TO HCV-INDUCED HEPATOCELLULAR CARCINOMA
RESECTION OF A RIGHT ATRIAL MASS IN A CARDIAC TRANSPLANT RECIPIENT USING A MINIMALLY-INVASIVE SURGICAL APPROACH
ADAPTIVE AND MALADAPTIVE SIGNALING AFTER MTOR INHIBITION IS MODULATED BY HORMONAL STATUS IN FEMALE CARDIOMYOCYTES
THE IMPACT OF ACUTE KIDNEY INJURY ON MORTALITY AND MORBIDITY IN PATIENTS AFTER LIVER TRANSPLANTATION
SURVIVAL OF MHC-DISPARATE SKIN GRAFTS IN RAT IS MODIFIED BY ADDITIONAL DIFFERENCES WITHIN THE NATURAL KILLER GENE COMPLEX (NKC)
DONOR HEARTS FROM PATIENTS WITH ACUTE PULMONARY EMBOLISM — A CONTRAINDICATION FOR HEART TRANSPLANTATION?
SUCCESSFUL BRIDGING TO HEART TRANSPLANTATION USING THE LEVITRONIX CENTRIMAG SYSTEM AND DURAHEART LVAD IN A PATIENT WITH RESUSCITATION RELATED LIVER INJURY
MONITORING OF ANTI-HLA AND ANTI-MICA ANTIBODIES IS NECESSARY IN PATIENTS WITH VENTRICULAR ASSIST DEVICE SUPPORT
INCISIONAL HERNIAS FOLLOWING LIVER TRANSPLANTATION -IMPACT OF INCISION AND IMMUNOSUPPRESSION
ANTIBODIES AGAINST MICA AND ANTI-HLA AFTER HEART TRANSPLANTATION ARE ASSOCIATED WITH CMV-INFECTION AND TRANSPLANT VASCULOPATHY
TRANSCATHETER AORTIC VALVE IMPLANTATION LONG-TERM AFTER HEART TRANSPLANTATION
KIDNEY TRANSPLANTATION WITH DONORS OVER THE EXPECTED LIFESPAN: A SINGLE CENTER ANALYSIS
THE INNSBRUCK HAND TRANSPLANT PROGRAM: A 10-YEAR REPORT
FUNCTIONAL IMPACT OF RENAL ISCHEMIA-REPERFUSION INJURY IN THE ABSENCE OF INFLAMMATORY CELLS
THE FITNESS OF BONE MARROW DERIVED MESENCHYMAL STEM CELLS — AN ANALYSIS OF CARDIOVASCULAR PREDICTORS
KIR GENOTYPE DETERMINES NK-CELL PERFORMANCE AGAINST K562
ONINVASIVE IN VIVO TRACKING OF MESENCHYMAL STEM CELLS BY MRI AND EVALUATION OF CELL THERAPEUTIC EFFECTS
DOSE PROPORTIONALITY OF MYCOPHENOLIC ACID IS LIMITED BY RENAL FUNCTION EARLY AFTER RENAL TRANSPLANTATION
COMPARING AORTIC STIFFNESS IN KIDNEY TRANSPLANT RECIPIENTS AND PATIENTS WITH RESIDUAL RENAL FUNCTION
RISK FACTORS IN PEDIATRIC LIVER TRANSPLANTATION
ESTABLISHMENT OF THE AREAL DENSITY MEASUREMENT AS A PROCEDURE FOR DETERMINATION OF THE ISLET DOSIS AND ITS APPLICATION FOR ISLET TRANSPLANTATION
HO-1 INDUCTION VIA NUTRACEUTICALS AMELIORATES RENAL ISCHEMIA REPERFUSION INJURY
CALCINEURIN-INHIBITOR-FREE THERAPIE WITH EVEROLIMUS AND MYCOPHENOLIC-ACID IN CARDIAC TRANSPLANT RECIPIENTS WITH CHRONIC KIDNEY DISEASE: EARLY FOLLOW UP
DONORS'ELIGIBILITY IN THE FRAME OF LIVING DONOR LIVER TRANSPLANTATION FROM THE PSYCHOSOMATIC PERSPECTIVE
SEX-SPECIFIC MODIFICATION OF THE RENAL CYP-EICOSANOID PROFILE LEADS TO ALTERATIONS IN TISSUE OXYGENATION AND INTRARENAL HEMODYNAMICS IN ISCHEMIC ACUTE KIDNEY INJURY
PSYCHOSOMATIC EVALUATION OF TRANSPLANT CANDIDATES: TRANSPLANT EVALUATION RATING SCALE OBJECTIFIES THE CLINICAL DECISION
PERCUTANEOUS TRANSLUMINAL STENT ANGIOPLASTY AS TREATMENT OF PANCREAS TRANSPLANT ARTERY STENOSIS
BRIDGE TO RECOVERY FOR ACUTE MYOCARDIAL FAILURE: SUPERIORITY OF PARACORPORAL COMPARED TO EXTRACORPORAL SUPPORT
INTERLEUKIN-33 PROLONGS ALLOGRAFT FUNCTION FOLLOWING HEART TRANSPLANTATION IN MICE
NONALCOHOLIC STEATOHEPATITIS AN INCREASING INDICATION FOR LIVER TRANSPLANTATIONEXPERIENCE OF THE UNIVERSITY HOSPITAL OF ESSEN
SAFETY STUDY OF MODIFIED HTK SOLUTION-FIRST RESULTS AFTER LIVERTRANSPLANTATION IN SWINE
ANTITHROMBIN III INHIBITS MICROVASCULAR THROMBUS FORMATION UNDER IMMUNOSUPPRESSIVE THERAPY IN POSTISCHEMIC TISSUE IN VIVO
URINARY INTERLEUKIN-6 IS INCREASED DURING REJECTION AFTER KIDNEY TRANSPLANTATION
LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS: AN ANALYSIS OF MEDICAL AND SURGICAL RISK FACTORS
HOW CAN A 56 HOURS ANHEPATIC PERIOD AFTER FULMINANT GRAFT FAILURE BE BRIDGED TO RE-TRANSPLANTATION?
PELVIC RECONSTRUCTIVE SURGERIES FOR PELVIC ORGAN PROLAPSE IN FEMALE KIDNEY TRANSPLANT RECIPIENTS
RIGHT-SIDED TRANSPERITONEAL HAND-ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY: IS THERE AN ISSUE WITH THE RENAL VESSELS?
THE IMPACT OF HAND-ASSISTED LAPAROSCOPIC LIVING DONOR NEPHRECTOMY ON DONOR'S QUALITY OF LIFE, EMOTIONAL AND SOCIAL STATE
POST-TRANSPLANT URINARY RETENTION DUE TO NEUROGENIC HYPOCONTRACTILE BLADDER: SUCCESSFUL IMPLANTATION OF SACRAL NEUROSTIMULATOR IN A KIDNEY TRANSPLANT RECIPIENT
SPONTANEOUS KIDNEY GRAFT RUPTURE CAUSED BY SEVERE PYELONEPHRITIS
SUCCESSFUL CASPOFUNGIN THERAPY IN TWO LIVING-DONOR LIVER RECIPIENTS WITH INVASIVE PULMONARY ASPERGILLOSIS
HEPATITIS C LIVER TRANSPLANTATION RECIPIENTS WITH ABCG8 AND MDR1 POLYMORPHISMS HAVE A SIGNIFICANTLY HIGHER PREVALENCE OF ADVANCED FIBROSIS
DONOR AND RECIPIENT BODY MASS INDEX CORRELATE WITH INITIAL KIDNEY GRAFT FUNCTION
IS CELL-FREE SOLUTION SUPERIOR TO BLOOD PERFUSION DURING EX-VIVO REPAIR OF DONOR LUNGS?
THE CAVAL ANASTOMOSIS TECHNIQUE DOES NOT INFLUENCE THE RENAL FUNCTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION -A GERMAN SINGLE CENTER EXPERIENCE
ARFI-BASED TISSUE ELASTICITY QUANTIFICATION AND KIDNEY GRAFT DYSFUNCTION: FIRST CLINICAL EXPERIENCES
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER LIVER TRANSPLANTATION IN THE MELD-ERA
LIVER TRANSPLANTATION FOR POLYCYSTIC LIVER DISEASE. THE UNIVERSITY HOSPITAL ESSEN EXPERIENCE
RESULTS OF KIDNEY TRANSPLANTATION AFTER RESCUE ALLOCATION
INTERVENTIONAL THERAPY OF VENA CAVA INFERIOR THROMBOSIS AFTER ORTHOTOPIC LIVER TRANSPLANTATION
ACTIVATION OF EXTRACELLULAR SIGNAL REGULATED KINASE PREDICTS OUTCOME IN CADAVERIC RENAL TRANSPLANTATION
LONG-TERM OUTCOMES AFTER ORTHOTOPIC LIVER TRANSPLANTATION IN HIV-INFECTED PATIENTS WITH END-STAGE LIVER DISEASE
LIVER TRANSPLANTATION A NEW RISK FACTOR FOR INTESTINAL INTUSSUSCEPTIONS
POLYOMAVIRUS BK VIRUS VIREMIA, BUT NOT THE INDIVIDUAL PLASMA VIRAL LOAD, IS SUGGESTIVE FOR BK NEPHROPATHY IN RENAL TRANSPLANT RECIPIENTS
HIGH INTRAHEPATIC VIRAL LOADS OF HHV6 BUT NEITHER OF CMV NOR EBV ARE ASSOCIATED WITH DECREASED GRAFT SURVIVAL IN LIVER TRANSPLANT RECIPIENTS WITH GRAFT HEPATITIS
BLOODPRESSURE, CHOLESTEROL LEVELS AND RENAL FUNCTION AFTER A SWITCH FROM CYCLOSPORIN TO TACROLIMUS: A 24 MONTHS FOLLOW UP OF 54 RENAL TRANSPLANT RECIPIENTS
ADVANCEMENT OF A BIOLOGICAL VENTRICULAR ASSIST DEVICE (BIO VAD®)
DEVELOPMENT OF A QUESTIONNAIRE ASSESSING MEDICATION ADHERENCE POST TRANSPLANTATION: COMPAD FRAGEBOGEN ZUR MEDIKAMENTENEINNAHME NACH TRANSPLANTATION
ASSESSMENT OF DONOR-SPECIFIC ALLOREACTIVITY AND REGULATORY T-CELL FREQUENCY -SUITABILITY IN LIVING DONOR KIDNEY TRANSPLANTATION?
IMPACT OF INCREASED SERUM FERRITIN CONCENTRATION PRIOR LIVER TRANSPLANTATION ON LONG-TERM SURVIVAL AFTER TRANSPLANTATION
TETRAHYDROBIOPTERIN (BH4) INCREASES KIDNEY INDOLEAMIN 2–3 DIOXYGENASE (IDO) AND ANELIORATES ISCHEMIA REPERFUSION INJURY
MOUSE HIND LIMB TRANSPLANTATION -A NEW COMPOSITE TISSUE ALLOTRANSPLANTATION (CTA) MODEL UTILIZING NON-SUTURE SUPERMICROSURGERY
EFFECT OF PROTEASOME INHIBITION BY BORTEZOMIB ON HLA-ANTIBODY TITERS AND SPECIFICITY IN SENSITIZED PATIENTS AWAITING RENAL ALLOGRAFT TRANSPLANTATION
EFFECTS OF DIFFERENT IMMUNOSUPPRESSIVE REGIMES ON LYMPHOCYTE SUBPOPULATIONS IN PERIPHERAL BLOOD AFTER ABO INCOMPATIBLE (ABO/) AND ABO COMPATIBLE (ABOC) KIDNEY TRANSPLANTATION (KTX) M.STRECKER, F. THAISS, B. NASHAN M. KOCH
1 YEAR FOLLOW UP OF ABOC AND ABOI LIVING RELATED KIDNEY TRANSPLANTATION: A CASE-CONTROL STUDY
SUBSETS OF CXCR3-EXPRESSING HUMAN CD4+ T CELLS EXERT IMMUNOREGULATORY FUNCTION
LOW DOSE ATG (THYMOGLOBULIN) INDUCTION FOR OLDER KIDNEY TRANSPLANT RECIPIENTS (“OLD FOR OLD”), SINGLE CENTRE EXPERIENCE OVER 4 YEARS
BONE METABOLISM AND FIBROBLAST GROWTH FACTOR 23 (FGF23) AFTER PEDIATRIC RENAL TRANSPLANTATION (PRT)
CHIMERISM STUDIES AND APPLICATION OF INFLIXIMAB IN A LIVER RECIPIENT WITH ACUTE GRAFT-VERSUS-HOST DISEASE POST LIVER TRANSPLANTATION MASKED BY CMV ENTERITIS
SUCCESSFUL COMBINED ATRIUM-LIVER TRANSPLANTATION FOR BUDD-CHIARI SYNDROME: CASE REPORT
OUTCOME FOLLOWING EARLY AND LATE LIVER RETRANSPLANTATION IN CHILDREN
RAPID STEROID-TAPER AND DE-NOVO-LOW-DOSE-IMMUNOSUPPRESSION WITH TACROLIMUS AND EVEROLIMUS IN PATIENTS WITH SPK
LIVER TRANSPLANTATION IN PATIENTS WITH LAB-MELD > 30: EXCELLENT RESULTS IN 54 PATIENTS AT UKT
IMMUNADSORPTION WITH PROTEIN A AND ORAL GALACTOSE THERAPY IN RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER RENAL TRANSPLANTATION
GENETICAL ANALYSIS OF THE BINDING SITES OF POLYCLONAL ANTITHYMOCYTE GLOBULINS (ATGS)
MODULATION OF ADIPONECTIN, A CARDIOVASCULAR HORMONE, IN THE MYOCARDIUM OF PATIENTS WITH CHRONIC HEART FAILURE
THYMOGLOBULIN INDUCTION IN LIVING DONOR KIDNEY TRANSPLANT RECIPIENTS
HIGH INCIDENCE OF HEPARIN-INDUCED THROMBOCYTOPENIA IN LIVER-TRANSPLANT RECIPIENTS
KIDNEY TRANSPLANTATION IN PREVIOUS HEART TRANSPLANTAT RECIPIENTS
DETECTION OF SIGNIFICANT CORONARY ARTERY STENOSIS WITH 64-SLICE MULTIDETECTOR ROW COMPUTED TOMOGRAPHY IN HEART TRANSPLANT RECIPIENTS
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM -CHOLANGIOCARCINOMA-SEQUENCE IN A PATIENT WITH PRIMARY SCLEROSING CHOLANGITIS
SUCCESSFUL LUNG RE-TRANSPLANTATION AFTER COMBINED LUNG-LIVER TRANSPLANTATION
A SIMPLE WAY TO AMELIORATE ISCHEMIA REPERFUSION INJURY WITH BILIRUBIN
SOLUBLE TFPI CAN INTERFERE WITH XENOGENIC ACTIVATION OF THE HUMAN COAGULATION SYSTEM AND PREVENTS COAGULOPATHY IN XENOPERFUSED KIDNEYS
ARE ADDITIONAL ANTIBODIES DETECTED BY LUMINEX SINGLE ANTIGEN TESTING CLINICALLY RELEVANT? A COLLABORATIVE TRANSPLANT STUDY REPORT
THE FIRST CASE OF SUCCESSFUL PEDIATRIC SMALL BOWEL TRANSPLANTATION IN GERMANY
AGONISTIC ANTIBODIES TO THE ANGIOTENSIN AT1-RECEPTOR AFTER KIDNEY TRANSPLANTATION
LUNG EMBOLISM IN LONG TERM FOLLOW UP AFTER THORACIC ORGAN TRANSPLANTATION
MELATONIN IN LIVER RESECTION: FIRST CLINICAL EXPERIENCE
PRESERVATION OF RENAL FUNCTION AT SURGERY FOR PERSISTING HYPERPARATHYROIDISM AFTER RENAL TRANSPLANTATION
HEPATOCYTE PROGENITOR TRANSPLANTS AS A POTENTIAL SOURCE FOR TREATMENT OF INSULIN DEPENDENT DIABETES MELLITUS
EVEROLIMUS ALLOWS EARLY CNI-REDUCTION AND LATE WITHDRAWAL IN HEART TRANSPLANT RECIPIENTS RESULTING IN IMPROVED RENAL FUNCTION
META-ANALYSIS OF INTERLEUKIN-2-RECEPTOR ANTAGONISTS FOR LIVER TRANSPLANT RECIPIENTS
NATIVE URETER REIMPLANTATION - AN EFFECTIVE THERAPY FOR URINARY TRACT COMPLICATIONS FOLLOWING KIDNEY TRANSPLANTATION
INVASIVE PULMONARY ASPERGILOSIS SUCCESSFULLY TREATED WITH THE COMBINATION OF VORICONAZOLE AND MICAFUNGIN IN A HEART TRANSPLANT RECIPIENT
THE RIGHT CHOICE FOR LAPAROSCOPIC DONOR NEPHRECTOMYTEN YEARS EXPERIENCE WITH 150 CASES
THE FIRST LAPAROSCOPIC DONOR NEPHRECTOMIES IN BANGLADESH - A FEASIBLE METHOD IN A DEVELOPING COUNTRY
FURTHER ASSESSMENT OF IATP (CYLEX IMMUKNOW®) IN PEDIATRIC LIVER TRANSPLANTATION (LTX) AND HEALTHY CONTROLS
VIRUS SAFETY AND XENOTRANSPLANTATION: STATE OF THE ART 2010
PDCA-BASED MICROSURGICAL TRAINING PROGRAM FOR RAT LIVER TRANSPLANTATION: AN EFFICIENT AND PRODUCTIVE WAY TO ACQUIRE MICROSURGICAL SKILLS
UROLOGICAL DE NOVO MALIGNANCIES AFTER KIDNEY TRANSPLANTATION -SINGLE CENTER EXPERIENCE
FEASIBLE RELEVANCE OF DUFFY AND KIDD ANTIGENS FOR KIDNEY TRANSPLANTATION: ACUTE GRAFT LOSS AFTER THIRD KIDNEY TRANSPLANTATION DUE TO RED BLOOD CELL ANTIBODIES
OXIDATION OF HMGB1 IN EFFLUENT OF COLD PRESERVED LIVER GRAFTS CAUSED ATTENUATION OF THE PRO-INFLAMMATORY ACTIVITY
G-CSF ENHANCED THE LPS-INDUCED INFLAMMATORY RESPONSE AFTER RAT LIVER RESECTION VIA UPREGULATION OF LBP
EFFECTS OF DONOR PRETREATMENT WITH DOPAMINE ON GRAFT FUNCTION AFTER HEART TRANSPLANTATION: DATA FROM A RANDOMIZED CONTROLLED TRIAL
ESTABLISHMENT OF A DIETARY MODEL TO INDUCE HEPATIC STEATOSIS IN RAT LIVING LIVER DONORS
TRANSPLANTATION, SUPERSTITION AND ASTROLOGICAL MYTHOLOGY: HOW MOON PHASES INFLUENCE SHORT-AND LONG-TERM OUTCOME AFTER LIVING DONOR KIDNEY TRANSPLANTATION
SOLUBLE HLA-G AS AN INDICATOR FOR GRAFT REJECTION IN KIDNEY AND KIDNEY/PANCREAS TRANSPLANTATION SUPERIOR TO SOLUBLE CD30 LEVELS
RELEVANCE OF NON-EXPRESSED HLA-CLASS I ALLELES FOUND IN TWO CASES OF BONE MARROW DONOR SEARCH
FEASIBLE RELEVANCE OF DUFFY AND KIDD ANTIGENS FOR KIDNEY TRANSPLANTATION: ACUTE GRAFT LOSS AFTER THIRD KIDNEY TRANSPLANTATION DUE TO RED BLOOD CELL ANTIBODIES
PANCREAS AND ISLET TRANSPLANTATION - COMPETITIVE OR COMPLEMENTARY?
LEVELS OF SMICA, AS DETECTED BY A HIGHLY SENSITIVE LUMINEX ASSAY, HIGHLY ASSOCIATE WITH GRAFT REJECTION
IMMUNOSUPPRESSANTS INDUCED CHANGES IN MICRO-AND MACROCIRCULATION: A PROSPECTIVE STUDY IN HEALTHY SUBJECTS AND PATIENTS AFTER KIDNEY TRANSPLANTATION USING INTRAVITAL MICROSCOPY, OXYGEN SPECTROSCOPY AND COLOUR-CODED ULTRASOUND
EVALUATION OF ORGAN DONOR CARD HOLDERS AMONG AN EMPLOYEE CLUSTER IN A MAJOR GERMAN CITY
GRAFT PRECONDITIONING WITH LOW-DOSE TACROLIMUS (FK506) AND NITRIC OXIDE INHIBITOR (AGH) REDUCES ACUTE REJECTION AFTER LIVER TRANSPLANTATION IN THE RAT
DIFFERENCES BETWEEN BIG AND SMALL ISLETS OR WHY DOES SIZE MATTER?
FIBRIN-BASED ENGINEERED HEART TISSUE (FBEHT): A POTENTIAL FUTURE STRATEGY TOWARDS CARDIAC REGENERATION?
ADULT LIVING DONOR LIVER TRANSPLANTATION (LDLT) WITHIN THE MELD PERIOD IN GERMANY. A MULTICENTERED RETROSPECTIVE ANALYSIS
TREATMENT OF BRAIN DEAD DONORS WITH ANTI-IL-6R MONOCLONAL ANTIBODY ATTENUATES THE EARLY AND LATE INFLAMMATORY IMMUNE RESPONSE
LOW PRETRANSPLANT SERUM ADIPONECTIN LEVELS ARE ASSOCIATED WITH ADVERSE ALLOGRAFT OUTCOMES IN KIDNEY TRANSPLANT RECIPIENTS
SUSTAINED RENAL IMPROVEMENT TO MMF AND CNI TAPER PROMOTES LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH CNI-RELATED NEPHROPATHY
FULL DOSE MYCOPHENOLATE MOFETIL (CELLCEPT®) WITH LOW DOSE TACROLIMUS OPTIMIZES RENAL FUNCTION IN LONG TERM RENAL TRANSPLANT PATIENTS; RESULTS OF THE TRANCEPT STAY STUDY
HYPERLIPIDEMIA, AN ADJUSTABLE RISK FACTOR AFTER CARDIAC TRANSPLANTATION: ANALYSIS OF 1007 HEART TRANSPLANT RECIPIENTS
ONE YEAR RESULTS OF AN INTENSIFIED DOSING OF ENTERIC-COATED MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS RESULTS IN IMPROVED EFFICACY WITHOUT COMPROMISING SAFETY
RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS ONE YEAR AFTER CONVERSION
A SINGLE DOSE OF AN ADJUVANTED INFLUENZA A H1N1 VACCINE (PANDEMRIX®) DOES NOT PROVIDE A PROTECTIVE IMMUNE RESPONSE IN THE MAJORITY OF RENAL TRANSPLANT RECIPIENTS
RISK FACTORS FOR BK-POLYOMAVIRUS INFECTION AFTER RENAL TRANSPLANTATION AND DISCONTINUATION OF MYCOPHENOLATE AS A WAY OF TREATMENT
PROGNOSTIC FACTORS FOR AND PREVALENCE OF BK-VIRUS INFECTION IN A CAUCASIAN RENAL TRANSPLANT POPULATION
BOTH DOPAMINE AND ITS DERIVATE N-OCTANOYL-DOPAMINE PROTECT CARDIOMYOCYTES AGAINST COLD PRESERVATION INJURY
ALTERATIONS IN GENE EXPRESSION PROFILE ASSOCIATED WITH RENAL ISCHEMIA-REPERFUSION INJURY ARE ATTENUATED BY HYDROXYFASUDIL MEDIATED RHO-KINASE INHIBITION IN A RAT MODEL OF ACUTE RENAL FAILURE
PKC-INHIBITOR SOTRASTAURIN ACTS CYTOPROTECTIVE AND ENHANCES RENAL GRAFT FUNCTION AFTER PROLONGED COLD PRESERVATION
IS CLOSED CIRCUIT DURING EX-VIVO LUNG PERFUSION FOR RECONDITIONING OF DAMAGED DONOR-LUNGS SUPERIOR TO OPEN CIRCUIT PERFUSION?
TAT-CRMA PREVENTS APOPTOTIC TISSUE DAMAGE IN MYOCARDIAL ISCHEMIA-REPERFUSION INJURY
DONOR ANTIGEN SPECIFIC REGULATORY T CELL FUNCTION AND OUTCOME IN KIDNEY TRANSPLANT RECIPIENTS
DUAL NON-HLA ANTIBODIES SIMULTANEOUSLY TARGETING ENDOTHELIAL AT1-AND ETA RECEPTORS INDUCE VASCULAR PROLIFERATION AND COAGULATION
ACTIVATION OF THE NKG2D-SYSTEM IN HUMAN RENAL CELLS - A POTENTIAL ROLE IN ORGAN TRANSPLANTATION
HLA-SPECIFIC ANTIBODIES REDUCE LONG TERM GRAFT SURVIVAL AND INCREASE THE INCIDENCE OF PROTEINURIA EPISODES IN RENAL TRANSPLANTATION
SINGLE NUCLEOTIDE POLYMORPHISMS OF CHEMOKINE RECEPTORS AND ATP-BINDING CASSETTE TRANSPORTER AND RISK OF BILIARY STRICTURES AFTER LIVER TRANSPLANTATION
CORRELATION OF CD4+CD25+FOXP3+ T CELLS AND IL-17 EXPRESSING CD4+ T CELLS IN PATIENTS WITH CHRONIC ALLOGRAFT DYSFUNCTION AFTER KIDNEY TRANSPLANTATION
THE PRESENCE OF DONORSPECIFIC LOW LEVEL, C3D FIXING ANTI-HLA ANTIBODIES BEFORE KIDNEY TRANSPLANTATION IS A RISK FACTOR FOR EARLY REJECTION EPISODES
INVESTIGATION OF THE EFFECT OF LOCAL INTRA-GRAFT TREATMENT WITH LYMPHOCYTE MIGRATORY BLOCKERS AND A KV1.3 POTASSIUM CHANNEL BLOCKER TOGETHER WITH SHORT-TERM SYSTEMIC IMMUNOSUPPRESSION ON SKIN REJECTION IN RECONSTRUCTIVE TRANSPLANTATION
IMPACT OF TOLL-LIKE RECEPTOR 2 EXPRESSION IN RENAL ALLOGRAFT REJECTION
EXPERIMENTAL TRANSPLANTATION: NOVEL IMMUNOSUPPRESSION USING THE JAK3-INHIBITOR R348
TREATMENT OF ENDOTHELIAL CELLS WITH ATG PREVENTS TRANSENDOTHELIAL MIGRATION OF LEUKOCYTES
DIFFERENTIAL EFFECTS OF CYCLOSPORIN A AND SIROLIMUS ON THE EXPRESSION OF NADPH OXIDASE ISOFORMS IN KIDNEY CELLS
INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND TREG SUPPORT ARE CRITICAL FOR CTLA4IG MEDIATED TOLERANCE INDUCTION TO SOLID ORGAN ALLOGRAFTS
IMMUNOGENICITY OF MESENCHYMAL STEM CELLS FROM THE UMBILICAL CORD LINE FOR REGENERATIVE THERAPIES
GENERATION OF GENETICALLY ENGINEERED LOW-ANTIGENICITY MHC I KNOCK-DOWN HUMAN EMBRYONIC STEM CELLS TO PREVENT IMMUNE REJECTION
MECHANISMS OF GROWTH FACTOR DETERMINED DIFFERENTIATION OF MESENCHYMAL STEM CELLS TO VASCULAR SMOOTH MUSCLE CELL OR FIBROBLASTIC LINEAGES
BONE MARROW MONONUCLEAR CELL TRANSPLANTATION IMPROVES VASCULARIZATION AND CARDIAC FUNCTION IN LEFT-VENTRICULAR HYPERTROPHY
LINEAGE CONVERSION OF SKELETAL MUSCLE DERIVED PRECURSOR CELLS INTO CARDIOMYOCYTES -A PROMISING AUTOLOGOUS CELL SOURCE FOR CARDIAC CELL THERAPY
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN EXPLANTED BUT NOT TRANSPLANTED KIDNEYS -A RETROSPEKTIVE ANALYSIS
INOSINE Symbol -MONOPHOSPHATE DEHYDROGENASE (IMPDH) ACTIVITY IN CHILDREN AND ADOLESCENTS: PHYSIOLOGICAL REGULATION AND RESPONSE TO MYCOPHENOLIC ACID (MPA) THERAPY
LIVING-DONOR KIDNEY TRANSPLANTATION IN CROSSMATCH-POSITIVE PATIENTS WITH PERITRANSPLANT IMMUNOADSORPTION AND ANTI-CD20 THERAPY
ASSESSMENT OF BIOMARKERS FOR THERAPEUTIC DRUG MONITORING OF MTOR-INHIBITORS AFTER HEART TRANSPLANTATION
THE ROLE OF B-CELLS, MONOCYTES AND T-CELLS IN TRANSPLANT GLOMERULOPATHY AND ACUTE REJECTION
ANTIVIRAL TREATMENT OF HCV RECURRENCE AFTER LIVER TRANSPLANTATION: IMPACT ON COSTS AND QUALITY OF LIFE
RECURRENCE-FREE LONG-TERM SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH ADVANCED HCC IS DEPENDENT FROM 18-F-FDG TUMOR UPTAKE
EVALUATION OF THE EARLY IV AND PO PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL (MMF) AFTER LIVER TRANSPLANTATION IN COMBINATION THERAPY WITH TACROLIMUS OR CYCLOSPORINE A -A PROSPECTIVE RANDOMIZED SINGLE CENTER TRIAL
ETHYL GLUCURONIDE HAIR ANALYSIS IMPROVES ASSESSMENT OF LONG-TERM ALCOHOL ABSTENTION IN LIVER TRANSPLANT CANDIDATES WITH ALCOHOLIC LIVER CIRRHOSIS
NON-INVASIVE ASSESSMENT OF SEVERE GRAFT FIBROSIS AND INFLAMMATION IN PATIENTS TRANSPLANTED FOR NON-HCV RELATED LIVER DISEASES
FAS LIGAND ON RENAL TUBULAR CELLS MEDIATES FRATRICIDE IN ACUTE KIDNEY FAILURE
BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY
BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS: TWO-YEAR OUTCOMES FROM THE BENEFIT-EXT STUDY
SAFETY PROFILE OF BELATACEPT IN KIDNEY TRANSPLANT RECIPIENTS FROM A POOLED ANALYSIS OF PHASE II AND PHASE III STUDIES
EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
CONVERSION TO AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS IMPROVES RENAL FUNCTION: 2 YEARS FOLLOW-UP OF THE ZEUS TRIAL
INFLUENCE OF PREFORMED DONOR-SPECIFIC NON-LYMPHOCYTOTOXIC ANTIBODIES AGAINST HUMAN LEUKOCYTE ANTIGENS ON RENAL ALLOGRAFT SURVIVAL
PROSPECTIVE IMMUNOLOGIC RISK STRATIFICATION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS -EARLY OUTCOME EVALUATION
OUTCOME OF PANCREAS AND KIDNEY GRAFTS IN PANCREAS TRANSPLANT (PAK/SPK) RECIPIENTS REQUIRING OPERATIVE REINTERVENTION FOR PANCREAS GRAFT-RELATED COMPLICATIONS
AGONIST OF GROWTH HORMONE RELEASING HORMONE AS A POTENTIAL EFFECTOR FOR SURVIVAL AND PROLIFERATION OF PANCREATIC ISLETS
KOMBINED KIDNEY-PANCREAS TRANSPLANTATION FOR PATIENTS WITH DIABETES MELLITUS TYPE II -A SINGLE-CENTER REPORT
INCIDENCE OF HYPERFIBRINOLYSIS DURING SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION
IMPLEMENTATION OF A NOVEL WEB-BASED REGISTRY FOR PAEDIATRIC KIDNEY TRANSPLANTATION IN CENTRAL EUROPE
EFFECT OF (VAL-)GANCICLOVIR ± CMV HYPERIMMUNOGLOBULIN ON EBV VIREMIA IN PEDIATRIC RENAL TRANSPLANTATION: SUBGROUP ANALYSIS OF A PROSPECTIVE MULTICENTER TRIAL
DEFINITION AND OUTCOME OF SMALL-AND LARGE-FOR-SIZE LIVER TRANSPLANTATION IN CHILDREN
DISTINCT CHANGES IN LYMPHOCYTE SUBPOPULATIONS AND EXPRESSION OF BAFF/BAFF-R AFTER PEDIATRIC KIDNEY TRANSPLANTATION
IMPACT OF DONOR-TRANSMITTED CORONARY ATHEROSCLEROSIS ON QUALITY OF LIFE (QOL) AND QUALITY-ADJUSTED LIFE YEARS (QALY) AFTER HEART TRANSPLANTATION
FOR THE INVESTIGATORS OF THE WAITING FOR A NEW HEART STUDY: FLUID AND SALT INTAKE PREDICT HIGH-URGENCY TRANSPLANTATION IN THE WAITING FOR A NEW HEART STUDY
LIVING KIDNEY DONORS' QUALITY OF LIFE IN THE FIRST YEAR: A PROSPECTIVE LONGITUDINAL STUDY WITH AN APPROPRIATE REFERENCE GROUP
ARE LIVER TRANSPLANTED CHILDREN MORE IMPULSIVE? ATTENTION AND EXECUTIVE FUNCTIONING AFTER PEDIATRIC LIVER TRANSPLANTATION
COMPLIANCE UNDER MODIFIED RELEASE TACROLIMUS IN CHRONIC STABLE PATIENTS AFTER HEART TRANSPLANTATION
MYOCARDIAL WALL MOTION AND DEFORMATION IMAGING ALLOW THE PROOF OF FUNCTIONALLY RELEVANCE FOR CARDIAC ALLOGRAFT REJECTIONS WHICH ARE UNDERESTIMATED BY MORPHOLOGIC GRADING
ANTIBODY RESPONSE AFTER A SINGLE DOSE OF AN AS03-ADJUVANTED SPLIT-VIRION INFLUENZA A (H1N1) VACCINE IN HEART TRANSPLANT RECIPIENTS
PRECONDITIONING REGIMES FOR THE INDUCTION OF TOLERANCE IN PORCINE ALLOGENEIC LUNG TRANSPLANTATION: PERSPECTIVES FOR CLINICAL APPLICABILITY
SURGICAL WOUND COMPLICATIONS IN DE NOVO HEART TRANSPLANT RECIPIENTS TREATED WITH EVEROLIMUS: INCIDENCE AND MANAGEMENT
EMPHASIS OF THERAPEUTIC DRUG MONITORING: PROTON PUMP INHIBITORS IMPACT CYCLOSPORINE DOSE/EXPOSURE RELATION IN DE NOVO HTXR TREATED WITH MMF OR EVEROLIMUS
EXTRACORPOREAL MEMBRANE OXYGENATION EXPERIENCE FOR LUNG FAILURE AFTER TRANSPLANTATION
LEVOSIMENDAN FOR PRIMARY GRAFT FAILURE AFTER HEART TRANSPLANTATION: A THREE-YEAR FOLLOW UP